Chi Hang Wong

2.3k total citations
62 papers, 1.7k citations indexed

About

Chi Hang Wong is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Chi Hang Wong has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Immunology. Recurrent topics in Chi Hang Wong's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Mechanisms and Therapy (6 papers). Chi Hang Wong is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Mechanisms and Therapy (6 papers). Chi Hang Wong collaborates with scholars based in Hong Kong, China and Singapore. Chi Hang Wong's co-authors include HY Li, C. W. Lam, Anthony M.‐H. Ho, Stephen Kwok‐Wing Tsui, Anthony T.�C. Chan, Brigette Ma, Theodore W. C. Lo, James P. Tam, Giang K. T. Nguyen and Dewi K. Rowlands and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Chi Hang Wong

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi Hang Wong Hong Kong 25 876 433 336 226 209 62 1.7k
Birgit Fehrenbacher Germany 21 1.2k 1.4× 489 1.1× 464 1.4× 368 1.6× 269 1.3× 50 2.2k
Jim Jinn‐Chyuan Sheu Taiwan 30 1.2k 1.4× 355 0.8× 384 1.1× 242 1.1× 467 2.2× 93 2.2k
Gangqiao Zhou China 26 1.2k 1.4× 602 1.4× 441 1.3× 205 0.9× 576 2.8× 82 2.4k
Chia‐Wei Hsu Taiwan 21 834 1.0× 211 0.5× 138 0.4× 235 1.0× 295 1.4× 38 1.5k
Kazuyoshi Ueno Japan 13 1.3k 1.5× 343 0.8× 339 1.0× 82 0.4× 223 1.1× 34 1.9k
Farhad Seif Iran 18 533 0.6× 282 0.7× 406 1.2× 105 0.5× 297 1.4× 76 1.7k
Winston Y. Lee United States 15 696 0.8× 187 0.4× 537 1.6× 109 0.5× 119 0.6× 24 1.5k
Yaqin Li China 24 1.1k 1.3× 321 0.7× 221 0.7× 124 0.5× 190 0.9× 160 2.0k
Mahadeo A. Sukhai Canada 22 700 0.8× 450 1.0× 67 0.2× 139 0.6× 395 1.9× 66 1.5k

Countries citing papers authored by Chi Hang Wong

Since Specialization
Citations

This map shows the geographic impact of Chi Hang Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Hang Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Hang Wong more than expected).

Fields of papers citing papers by Chi Hang Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Hang Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Hang Wong. The network helps show where Chi Hang Wong may publish in the future.

Co-authorship network of co-authors of Chi Hang Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Chi Hang Wong. A scholar is included among the top collaborators of Chi Hang Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Hang Wong. Chi Hang Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Chi Hang, Anthony W.H. Chan, Landon L. Chan, et al.. (2024). PEG-BCT-100 and Canavanine Synergistically Induce Apoptosis in Arginine Biosynthetic Enzyme-Deficient Pancreatic Cancer. Cancer Research Communications. 4(12). 3180–3189. 1 indexed citations
2.
Hui, Connie W. C., Chi Hang Wong, Kwok Wai Lo, et al.. (2023). Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models. Investigational New Drugs. 41(5). 699–709. 2 indexed citations
3.
Juvina, Ion, et al.. (2023). Peer‐Assisted Learning Is More Effective at Higher Task Complexity and Difficulty. Topics in Cognitive Science. 16(1). 129–153. 1 indexed citations
4.
Leung, Agnes Sze Yin, Jaime S. Rosa Duque, Gilbert T. Chua, et al.. (2021). Changing pattern of pediatric anaphylaxis in Hong Kong, 2010–2019. Pediatric Allergy and Immunology. 33(1). e13685–e13685. 12 indexed citations
5.
Lau, Tat‐San, Loucia Kit Ying Chan, Gene Chi Wai Man, et al.. (2020). Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis. Cancer Immunology Research. 8(8). 1099–1111. 147 indexed citations
6.
Hui, Edwin P., Brigette Ma, W.K. Lam, et al.. (2020). Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy. Annals of Oncology. 31(6). 769–779. 72 indexed citations
7.
Wong, Chi Hang, et al.. (2020). IDDF2020-ABS-0213 CXCR2 blockade disrupts tumor trafficking of MDSC to potentiate immunotherapy efficacy. Abstracts. A3.1–A3. 1 indexed citations
8.
Hui, Edwin P., Brigette Ma, Herbert H. Loong, et al.. (2018). Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study. Clinical Cancer Research. 24(5). 1030–1037. 41 indexed citations
9.
Wong, Chi Hang, Brigette Ma, Connie W. C. Hui, et al.. (2018). Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma. Scientific Reports. 8(1). 8010–8010. 26 indexed citations
10.
Wong, Chi Hang, et al.. (2015). Preclinical evaluation of afatinib (BIBW2992) in esophageal squamous cell carcinoma (ESCC).. PubMed. 5(12). 3588–99. 22 indexed citations
11.
Wong, Chi Hang, Herbert H. Loong, Connie W. C. Hui, et al.. (2013). Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma. Investigational New Drugs. 31(6). 1399–1408. 27 indexed citations
12.
Ma, Brigette, Vivian Wai Yan Lui, Connie W. C. Hui, et al.. (2013). Preclinical evaluation of the mTOR–PI3K inhibitor BEZ235 in nasopharyngeal cancer models. Cancer Letters. 343(1). 24–32. 25 indexed citations
13.
Wong, Chi Hang, et al.. (2012). In Vivo FRET Imaging Revealed a Regulatory Role of RanGTP in Kinetochore-Microtubule Attachments via Aurora B Kinase. PLoS ONE. 7(9). e45836–e45836. 8 indexed citations
14.
Wong, Chi Hang, et al.. (2010). Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis. Cell Death and Disease. 1(7). e57–e57. 51 indexed citations
15.
Wong, Chi Hang, et al.. (2010). Caspase-3-mediated degradation of condensin Cap-H regulates mitotic cell death. Cell Death and Differentiation. 18(6). 996–1004. 24 indexed citations
16.
Wong, Chi Hang, et al.. (2008). Apoptotic histone modification inhibits nuclear transport by regulating RCC1. Nature Cell Biology. 11(1). 36–45. 47 indexed citations
17.
Ho, Anthony M.‐H., Chi Hang Wong, & C. W. Lam. (2008). Tumor necrosis factor-α up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways. Immunobiology. 213(7). 533–544. 111 indexed citations
18.
Wong, Chi Hang, et al.. (2008). Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris. Virus Genes. 38(1). 1–9. 11 indexed citations
19.
Wong, Chi Hang, et al.. (2008). Perturbation of the chromosomal binding of RCC1, Mad2 and survivin causes spindle assembly defects and mitotic catastrophe. Journal of Cellular Biochemistry. 105(3). 835–846. 13 indexed citations
20.
Waye, Mary Miu Yee, Patrick T.W. Law, Chi Hang Wong, et al.. (2005). The 3a protein of SARS-coronavirus induces apoptosis in vero E6 cells. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birgit Fehrenbacher Breakdown of academic impact, for papers by Jim Jinn‐Chyuan Sheu Breakdown of academic impact, for papers by Gangqiao Zhou Breakdown of academic impact, for papers by Chia‐Wei Hsu Breakdown of academic impact, for papers by Kazuyoshi Ueno Breakdown of academic impact, for papers by Farhad Seif Breakdown of academic impact, for papers by Winston Y. Lee Breakdown of academic impact, for papers by Yaqin Li Breakdown of academic impact, for papers by Mahadeo A. Sukhai
Rankless by CCL
2026